Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$40.4 - $59.1 $21,614 - $31,618
535 Added 3.49%
15,851 $644,000
Q1 2023

May 12, 2023

BUY
$38.16 - $48.86 $9,730 - $12,459
255 Added 1.69%
15,316 $741,000
Q4 2022

Feb 09, 2023

SELL
$33.53 - $54.79 $17,837 - $29,148
-532 Reduced 3.41%
15,061 $574,000
Q3 2022

Nov 10, 2022

BUY
$41.85 - $53.85 $652,567 - $839,683
15,593 New
15,593 $783,000
Q3 2021

Nov 12, 2021

SELL
$37.01 - $44.74 $2.38 Million - $2.87 Million
-64,228 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$37.95 - $49.37 $97,948 - $127,423
-2,581 Reduced 3.86%
64,228 $2.71 Million
Q1 2021

May 14, 2021

SELL
$46.8 - $68.92 $495,377 - $729,518
-10,585 Reduced 13.68%
66,809 $3.16 Million
Q4 2020

Feb 25, 2021

BUY
$47.96 - $67.64 $3.71 Million - $5.23 Million
77,394 New
77,394 $4.72 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.